These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4399497)

  • 21. Uptake and retention of 3H-noradrenaline in adrenergic nerve terminals after reserpine and axotomy.
    Häggendal J; Dahlström A
    Eur J Pharmacol; 1970; 10(3):411-5. PubMed ID: 4316282
    [No Abstract]   [Full Text] [Related]  

  • 22. Catecholamine fluorescence in the brains of chemically sympathectomized adult rats: increased fluorescence in bulbospinal neurons.
    Lorez HP
    Brain Res; 1977 Jun; 128(2):361-8. PubMed ID: 326351
    [No Abstract]   [Full Text] [Related]  

  • 23. Electron-microscopic localization of tritiated norepinephrine in rat brain: effect of drugs.
    Aghajanian GK; Bloom FE
    J Pharmacol Exp Ther; 1967 Jun; 156(3):407-16. PubMed ID: 6027453
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of chronic pretreatment with small doses of reserpine upon adrenergic nerve function.
    Antonaccio MJ; Smith CB
    J Pharmacol Exp Ther; 1974 Mar; 188(3):654-67. PubMed ID: 4816332
    [No Abstract]   [Full Text] [Related]  

  • 25. Blockade of L-dopa reversal of reserpine-induced conditioned avoidance response suppression by disulfiram.
    Seiden LS; Peterson DD
    J Pharmacol Exp Ther; 1968 Sep; 163(1):84-90. PubMed ID: 5673718
    [No Abstract]   [Full Text] [Related]  

  • 26. L-Dopa and imipramine: biochemical and behavioral interaction.
    Friedman E; Gershon S
    Eur J Pharmacol; 1972 May; 18(2):183-8. PubMed ID: 5037381
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of L-dopa on accumulation and efflux of monoamines in particles of rat brain homogenates.
    Ng LK; Colburn RW; Kopin IJ
    J Pharmacol Exp Ther; 1972 Nov; 183(2):316-25. PubMed ID: 5083548
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in the concentration and intracellular distribution of brain catecholamines: the effects of reserpine. beta-phenyliso-propylhydrazine, pyrogallol and 3,4-dihydroxyphenyl alanine, alone and in combination.
    WEIL-MALHERBE H; POSNER HS; BOWLES GR
    J Pharmacol Exp Ther; 1961 Jun; 132():278-86. PubMed ID: 13783846
    [No Abstract]   [Full Text] [Related]  

  • 29. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
    Lidbrink P; Jonsson G; Fuxe K
    Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
    [No Abstract]   [Full Text] [Related]  

  • 30. Plasma corticosterone changes following alterations in brain norepinephrine and serotonin.
    McKinney WT; Prange AJ; Majchowicz E; Schlesinger K
    Dis Nerv Syst; 1971 May; 32(5):308-13. PubMed ID: 4397134
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective protection of serotonin stores against the action of reserpine by -methyl-5-hydroxytryptpohan pretreatment.
    Lahti RA; Platz PA
    Biochem Pharmacol; 1969 Oct; 18(10):2363-9. PubMed ID: 4397869
    [No Abstract]   [Full Text] [Related]  

  • 32. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on central and peripheral noradrenaline neurons using a new dopamine-(beta)-hydroxylase inhibitor.
    Corrodi H; Fuxe K; Hamberger B; Ljungdahl A
    Eur J Pharmacol; 1970 Oct; 12(2):145-55. PubMed ID: 5472868
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of apomorphine on motility in rats.
    Maj J; Grabowska M; Gajda L
    Eur J Pharmacol; 1972 Feb; 17(2):208-14. PubMed ID: 5026397
    [No Abstract]   [Full Text] [Related]  

  • 35. Correlation of the recovery of the granular uptake-storage mechanism and the nerve impulse induced release of ( 3 H)noradrenaline after reserpine.
    Almgren O; Lundborg P
    J Pharm Pharmacol; 1971 Sep; 23(9):671-7. PubMed ID: 4398245
    [No Abstract]   [Full Text] [Related]  

  • 36. Serotonin depletion induced by reserpine is attenuated by prophylactic administration of lithium.
    Reches A; Liu KP; Karpiak SE; Fahn S; Cooper TB; Suckow R; Jackson V; Tamir H
    Eur J Pharmacol; 1985 Jul; 113(2):225-31. PubMed ID: 2412842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An assay procedure for tryptamine in brain and spinal cord using its (3H)dansyl derivative.
    Snodgrass SR; Horn AS
    J Neurochem; 1973 Sep; 21(3):687-96. PubMed ID: 4147502
    [No Abstract]   [Full Text] [Related]  

  • 38. [Effect of DOPA and reserpine on development of neurogenic gastric dystrophy].
    Zabradin ON
    Farmakol Toksikol; 1969; 32(5):559-61. PubMed ID: 5364667
    [No Abstract]   [Full Text] [Related]  

  • 39. Contribution of serotonin neurons to the functional recovery after spinal cord injury in rats.
    Hashimoto T; Fukuda N
    Brain Res; 1991 Jan; 539(2):263-70. PubMed ID: 1829012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of some drugs on central monoamine nerve terminals lacking nerve impulse flow.
    Andén NE; Fuxe K; Hökfelt T
    Eur J Pharmacol; 1967 May; 1(3):226-32. PubMed ID: 5234370
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.